HUMPHREY RACHEL sold 16.0% of their position (15.50K shares) of PYXIS ONCOLOGY, INC. on the open market
Open‑market sale worth $15.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/25/2026ACC: 0000905148-26-001434
-15.50K
Net shares
Net seller
$15.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
15.50K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.40K
Price / share
$0.97
Trade value
$1.36K
% of position
1.4%
4/14/2025
96.81K→95.41K
Common Stock
Direct
Shares
−200.00
Price / share
$0.97
Trade value
$194.00
% of position
0.2%
4/17/2025
95.41K→95.20K
Common Stock
Direct
Shares
−13.90K
Price / share
$1.03
Trade value
$14.36K
% of position
14.6%
4/21/2025
95.20K→81.31K
Total
Net shares
−15.50K
Net value
-$15.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/14/2025 | S · Sale | −1.40K | $0.97 | $1.36K | 1.4% | 96.81K | 95.41K |
| Common Stock Direct | 4/17/2025 | S · Sale | −200.00 | $0.97 | $194.00 | 0.2% | 95.41K | 95.20K |
| Common Stock Direct | 4/21/2025 | S · Sale | −13.90K | $1.03 | $14.36K | 14.6% | 95.20K | 81.31K |
| Total | −15.50K | -$15.92K | ||||||
Derivative Transactions0
No derivative transactions reported